Interleukin 33: A switch-hitting cytokine

Current Opinion in Immunology

Volumn 28, Issue 1, 2014, Pages 102-106

  Villarreal, Daniel O ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33;

ANTITUMOR IMMUNITY; ANTIVIRAL PROTECTIVE IMMUNITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VACCINATION; VIRUS INFECTION;

ANIMALS; CYTOKINES; HUMANS; INTERLEUKINS; NEOPLASMS; TH1 CELLS; TH2 CELLS;

EID: 84900988277     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.03.004     Document Type: Review

References (40)

1. Onda H., Kasuya H., Takakura K., Hori T., Imaizumi T., Takeuchi T., Inoue I., Takeda J. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1999, 19:1279-1288.
2. Baekkevold E.S., Roussigne M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., Brandtzaeg P., Erard M., Haraldsen G., Girard J.P. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003, 163:69-79.
3. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
4. Xu D., Chan W.L., Leung B.P., Huang Fp, Wheeler R., Piedrafita D., Robinson J.H., Liew F.Y. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998, 187:787-794.
5. Pushparaj P.N., Tay H.K., H'Ng S.C., Pitman N., Xu D., McKenzie A., Liew F.Y., Melendez A.J. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 2009, 106:9773-9778.
6. Matsuba-Kitamura S., Yoshimoto T., Yasuda K., Futatsugi-Yumikura S., Taki Y., Muto T., et al. Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis. Int Immunol 2010, 22:479-489.
7. Rankin A.L., Mumm J.B., Murphy E., Turner S., Yu N., McClanahan T.K., Bourne P.A., Pierce R.H., Kastelein R., Pflanz S. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010, 184:1526-1535.
8. Hazlett L.D., McClellan S.A., Barrett R.P., Huang X., Zhang Y., Wu M., et al. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2010, 51:1524-1532.
9. Solarski B., Kurowska-Stolarska M., Kewin P., Xu D., Liew F.Y. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010, 185:3472-3480.
10. Bonilla W.V., Frohlich A., Senn K., Kallert S., Fernandez M., Johnson S., et al. The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses. Science 2012, 335:984-989.
11. Moussion C., Ortega N., Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'Alarmin'?. PLoS ONE 2008, 3.
12. Kakkar R., Hei H., Dobner S., Lee R.T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 2012, 287:6941-6948.
13. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 2009, 106:9021-9026.
14. Luthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
15. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Küchler A.M. IL33-cytokine of dual function or novel alarmin?. Trends Immunol 2009, 30:227-233.
16. Smithgall M.D., Comeau M.R., Yoon B.R., Kaufman D., Armitage R., Smith D.E. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 2008, 20:1019-1030.
17. Pecaric-Petkovic T., Didichenko S.A., Kaempfer S., Spiegl N., Dahinden C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
18. Moulin D., Donze O., Talabot-Ayer D., Mezin F., Palmer G., Gabay C. IL-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007, 40:216-225.
19. Suzukawa M., Iikura M., Koketsu R., Nagase H., Tamura C., Komiya A., Nakae S., Matsushima K., Ohta K., Yamamoto K., Yamaguchi M. An IL-1 cytokine member, Il-33 induces human basophil activation via its ST2 Receptor. J Immunol 2008, 81(9):5981-5989. 1.
20. Cherry W.B., Yoon J., Bartemes K.R., Lijima K., Kita H. A novel IL-1 family cytokine, Il-33, potently activates human eosinophils. J Allergy Clin Immunol 2008, 121:1484-1490.
21. Schneider E., Petit-Bertron A.F., Bricard R., Levasseur M., Ramadan A., Girard J.P., Herbelin A., Dy M. IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol 2009, 183:3591-3597.
22. Rank M.A., Kobayashi T., Kozaki H., Bartemes K.R., Squillace D.L., Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol 2009, 123:1047-1054.
23. Bourgeois E., Van L.P., Samson M., Diem S., Barra A., Roga S., et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009, 39:1046-1055.
24. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 2007, 104:282-287.
25. Talabot-Ayer D., Lamacchia C., Gabay C., Palmer G. IL-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 2009, 284:19420-19426.
26. Michael M.U. Special aspects of Interleukin-33 and the IL-33 receptor complex. Semin Immunol 2013, 25:449-457.
27. Palmer G., Gabay C. Interleukin 33 biology with potential insights into human diseases. Nat Rev Rheumatol 2011, 7:321-329.
28. Hayakawa M., Hayakawa H., Matsuyama Y., Tamemoto H., Okazaki H., Tominaga S. Mature Interleukin-33 is produced by calpain-mediated cleavage in vivo. Biocjem Biophys Res Commun 2009, 387:218-222.
29. Lefrancais E., Roga S., Gautier V., Gonzalez-de-Peredo A., Monsarrat B., Girard J.P., et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 2012, 109:1673-1678.
30. Roussel L., Erard M., Cayrol C., Girard J.P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 2008, 9:1006-1012.
31. Kakkar R., Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008, 7:827-840.
32. Luzina I.G., Pickering E.M., Kopach P., Kang P.H., Locatell V., Todd N.W., Papadimitriou J.C., McKenzie A.N., Atamas S.P. Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J Immunol 2012, 189:403-410.
33. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10:103-110.
34. Yang Q., Li G., Zhu Y., Liu L., Chen E., Turnquist H., et al. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8(+) T cells. Eur J Immunol 2011, 41:3351-3360.
35. Villarreal D.O., Wise M.C., Walters J.N., Reuschel E., Choi M.J., Obeng-Adjei N., Yan J., Morrow M.P., Weiner D.B. Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Caner Res 2014, [Epub ahead of print].
36. Miller A.M. Role of IL-33 in inflammation and disease. J Inflamm (Lond) 2011, 8:22.
37. Gao K., Li X., Zhang L., bai L., Dong W., Gao K., Shi G., Xia X., Wu L., Zhang L. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice. Cancer Lett 2013, 335:463-471.
38. Komai-Koma M., Xu D., Li Y., McKenzie A.N., McInnes I.B., Liew F.Y. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007, 37:2779-2786.
39. Kurowska-Stolarska M., Kewin P., Murphy G., Russo R.C., Stolarski B., Garcia C.C., Komai-Koma M., Pitman N., Li Y., Niedbala W., McKenzie A.N., Teixeira M.M., Liew F.Y., Xu D. IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008, 181:4780-4790.
40. Guo L., Wei G., Zhu J., Liao W., Leonard W.J., Zhao K., Paul W. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 2009, 106:13463-13468.